000 | 01923 a2200553 4500 | ||
---|---|---|---|
005 | 20250517051612.0 | ||
264 | 0 | _c20160706 | |
008 | 201607s 0 0 eng d | ||
022 | _a1534-6080 | ||
024 | 7 |
_a10.1097/TP.0000000000000861 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKumar, Deepali | |
245 | 0 | 0 |
_aRandomized Controlled Trial of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Kidney Transplant Recipients. _h[electronic resource] |
260 |
_bTransplantation _cMar 2016 |
||
300 |
_a662-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
650 | 0 | 4 |
_aInfluenza A Virus, H3N2 Subtype _ximmunology |
650 | 0 | 4 |
_aInfluenza B virus _ximmunology |
650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aInfluenza, Human _ximmunology |
650 | 0 | 4 |
_aIsoantibodies _xblood |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOff-Label Use |
650 | 0 | 4 | _aOntario |
650 | 0 | 4 |
_aPolysorbates _xadministration & dosage |
650 | 0 | 4 |
_aSqualene _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVaccines _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aCampbell, Patricia | |
700 | 1 | _aHoschler, Katja | |
700 | 1 | _aHidalgo, Luis | |
700 | 1 | _aAl-Dabbagh, Mona | |
700 | 1 | _aWilson, Leticia | |
700 | 1 | _aHumar, Atul | |
773 | 0 |
_tTransplantation _gvol. 100 _gno. 3 _gp. 662-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/TP.0000000000000861 _zAvailable from publisher's website |
999 |
_c25228152 _d25228152 |